Multiple choice

Which of the following statements regarding the treatment of hormone refractory prostate cancer in males is correct?

  1. Docetaxel and prednisolone have been shown to increase median survival of the prostrate patients by 3 to 4 months .

  2. Mitoxantrone has been observed to increase median survival of the patient approximately by 1 to 2 months.

  3. Withdrawing anti-androgen treatment gives no benefits to the sufferers of prostate cancer .

  4. Intravenous radio-isotope therapy has been observed to increase median survival of the patient by 6 to 8months .
Reveal answer Fill a bubble to check yourself
A Correct answer
Explanation

It is correct. In the treatment of hormone refractory prostate cancer, docetaxel and prednisolone have been shown to increase median survival of the prostrate patients by 3 to 4 months .

Keep practicing — related questions